Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Ann Thorac Surg. 2009 Dec;88(6):2052-60. doi: 10.1016/j.athoracsur.2009.08.033.
Metastasectomy is the only curative option for some patients with secondary pulmonary malignancy. Many studies suggest a survival benefit in selected patients if complete resection of pulmonary metastases is accomplished. There are several operative approaches that may be used, with the goal of complete resection and with minimal parenchymal loss. Evaluation for resection must include ascertainment of control of the primary tumor and assessment of the ability to achieve complete resection. Minimally invasive approaches may offer advantages in quality of life outcomes, with equivalent oncologic outcomes.
肺转移瘤切除术是部分继发性肺部恶性肿瘤患者的唯一根治性选择。多项研究表明，如果能够完全切除肺部转移瘤，某些特定患者可从中获益。为了达到完全切除且尽量减少肺实质损失的目标，可能会采用几种手术方法。切除评估必须包括确定原发性肿瘤的控制情况和评估能否完全切除。微创方法在生活质量结局方面可能具有优势，且具有相同的肿瘤学结局。
